Pfizer PFE Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $63.32B+1.2% | $62.58B-0.3% | $62.79B-1.6% | $63.83B+2.2% | $62.46B-1.8% | ||
| $16.77B+4.4% | $16.07B-3.8% | $16.7B-6.1% | $17.8B+2.8% | $17.32B-3.0% | ||
| $46.55B+0.1% | $46.51B+0.9% | $46.08B+0.1% | $46.04B+2.0% | $45.15B-1.4% | ||
| 73.5%-0.8pp | 74.3%+0.9pp | 73.4%+1.3pp | 72.1%-0.2pp | 72.3%+0.3pp | ||
| $13.72B-0.5% | $13.79B-0.8% | $13.91B-0.4% | $13.96B-2.1% | $14.27B-3.2% | ||
| —— | —— | $9.16B-13.1% | $10.54B+42.5% | $7.4B-7.9% | ||
| $384M+244% | -$266M+61.2% | -$685M-191% | -$235M+53.9% | -$510M-1,721% | ||
| —— | —— | $9.83B-8.6% | $10.75B+36.4% | $7.88B-1.8% | ||
| —— | —— | $1.72-8.5% | $1.88+36.2% | $1.38-2.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pfizer's revenue?
- Pfizer (PFE) generated $63.3B in revenue over the trailing twelve months, up 1.4% year over year.
- Is Pfizer profitable?
- Pfizer reported $12.1B in net income over the trailing twelve months, a 15.7% net margin.
- What is Pfizer's earnings per share?
- Pfizer's diluted EPS over the trailing twelve months is $2.12.
- Where does Pfizer's income statement data come from?
- Every line is extracted from Pfizer's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
